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major modern biotechnologies amongst a larger public is
indispensable. The aim of this article is to describe four major
modern biotechnologies, their applications and the inputs they
require, i.e. in vitro technologies, detection technologies, genomics
and genetic modification. Although the last application is
discussed in more detail, care should be taken not to equate
biotechnology to genetic modification of living organisms.
In-vitro technologies
The meaning of the Latin words ‘in vitro’ is ‘in glass’. In-vitro
technologies separate parts of living organisms in closed
containers to manipulate and maintain this material. Several well-
known and relatively older applications belong to this category.
Plant tissue culture became established in the 1970s. It involves
the maintenance of plant material (complete plants, specific
organs or cells) under sterile conditions and in the presence of
nutrients. Plant tissue culture allows the rapid multiplication of
crop plants at a small scale in comparison to ‘in vivo’ (living)
conditions. Starter material for crops can thus be supplied in large
quantities, solving bottle-necks in supply to farmers. Particularly
for crops that are propagated vegetatively (not through seed), plant
tissue culture forms a useful instrument to multiply starter
material. Plant tissue culture also allows for the cleaning of virus-
infected starter material. A third use of plant tissue culture is to
conserve useful crop genetic resources in a less vulnerable
environment than in the field. Finally, plant tissue culture, done 
in-vitro, can be used to transfer useful traits from wild relatives
into crop varieties by crossing sexual barriers that do not take
place under normal (in vivo) conditions. 
Nowadays, more than a thousand plant species are being
propagated in tissue culture. The costs of plant tissue culture are
modest. A new banana plant of a desired variety can be produced
and made available at less than one US dollar. This option also
offers the added benefit of providing healthy planting material. Oil
palm, cassava, potato and ornamentals are also propagated in-
vitro. The only facilities required are two rooms: one in which the
material can be handled under sterile conditions, and the other a
growth room with the necessary light, temperature and humidity.
Basic training is adequate to teach the principles of sterile
handling of material. Local communities who have been trained to
do so and have access to the facilities can manage in vitro growth.
In-vitro technologies are also used in animal husbandry. Artificial
insemination of cattle is a rather old application, in which sperm is
stored under sterile conditions at low temperatures for large-scale
insemination. Modern extensions of this technology are: “in vitro
fertilisation”, in which a sperm and an egg cell are made to fuse,
thus speeding up the generation of new breeds; “embryo transfer”,
which allows the use of carrier animals for the new offspring to
develop; and “cryopreservation”, the storage of valuable starter
material at very low temperatures. Evidently, these applications are
being used both in animal breeding, and for the conservation of
animal diversity. Except for artificial insemination, which is a low-
cost application, the costs here are much higher than for plant tissue
culture and require more advanced facilities.
Detection technologies
Detection technology has been developed to detect the presence
or absence of specific traits in individual organisms. A major
part of this technology is the use of an array of DNA marker
techniques. These marker techniques make use of patterns of
specific DNA sequences (the building blocks of all genetic
information) that reveal the genetic difference between two
individual organisms. This technology has considerably
increased the speed of plant and animal breeding. If DNA marker
sequences are linked to specific traits, such sequences can be
used to search for the presence these traits in the offspring of a
cross breeding, long before the trait is actually expressed. A
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From traditional to modern biotechnologies 
The brewing of beer from barley or bananas, wine making, the
fermentation of milk into various products such as yoghurt and
cheese as well as of soybean into curd, the combination of cereals
and pulses to improve nitrogen availability, the use of
ethnoveterinary vaccines to protect cattle are all examples of
traditional biotechnology. According to the Convention on
Biological Diversity (1992) biotechnology is defined as ‘any
technological application that uses biological systems, living
organisms, or derivatives thereof, to make or modify products or
processes for specific use’. The keywords in this definition are
living, technological, and products. Biotechnology that has been
developed and utilised by humans over the ages falls within the
parameters of this definition. However, it is not this traditional
use of biotechnology that has brought it into the focus of current
global debate. 
Recent sharp increase in the knowledge of biological science
(biochemistry, molecular biology, genetics) has complemented
these traditional forms of biotechnology with modern applications.
Not only are modern biotechnologies based on new scientific
knowledge, they also depend largely on the availability of capital
and skilled human resources. This makes biotechnology a
specialised affair and takes it into the realms of private research
funded by multinational corporations. And it is this trend in
biotechnology and the perceived risks that has aroused the present
debate. 
Much of the debate is centred on two questions: (a) who
determines which applications to develop and where to apply? (b)
who benefits from those applications? To widen the public debate
and to render the discussions productive, a basic knowledge of
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major aspect of these techniques is that they do not alter the
DNA (the genes, the traits). Instead they just allow a fast
appraisal of what can be found in the offspring of a breeding
programme. Various forms have been developed over the last
fifteen years that differ in robustness, costs, facilities needed, and
the type of information provided.
In comparison to in-vitro technologies, costs in this case are
higher and the facilities required are more advanced. Until now,
the extent to which this technology is applied in plant and animal
breeding and its impact is much larger than that of genetic
modification (see below), because it requires less time and
financial investments. These techniques are being applied in
small-scale agriculture as in a maize-breeding project aiming to
increase the drought tolerance in local maize germplasm in
Kenya and Zimbabwe. Markers have also been used to better
understand farmers’ selection of local rice varieties in the
Philippines and Vietnam, and to more efficiently maintain the
genetic diversity in enset, a staple crop of small-scale farmers in
Ethiopia.
Monoclonal antibodies constitute another biotechnological
detection technology. Cells derived from the immune system that
produce specific antibodies are maintained and multiplied in-
vitro for the production of large amounts of antibodies that can
be used to search for specific material. Apart from main
applications in health care, the technology is being used in
agriculture to detect pathogens (agents causing pests and
diseases) in plants and animals, thus allowing accurate pest and
disease management. These technologies are used to provide the
pest/disease free import guarantees on products as required by
many countries, facilitating cross-border exchange of plants and
animals. Whereas the costs for the development of monoclonal
cells producing specific antibodies are high and specialist
expertise is needed, the use of such monoclonal cells and their
antibodies is relatively simple and requires only modest
facilities.
Genomics
Genomics is a field of biology that has developed very rapidly
over the last decade. It involves the large-scale sequencing of
DNA, including entire genomes (all the DNA of a single
individual), and the comparative analysis of the resulting
sequences across species barriers. Major highlights in this field are
the sequencing of the total DNA of man, but also of a substantial
number of micro-organisms (model organisms, pathogens and
organisms used in traditional biotechnology), of plants (including
rice) and of animals. Genomics produces enormous datasets and a
complete new science, bio-informatics, has been developed to
handle these databases and to allow retrieval and analysis of the
information they contain. The costs of genomics research are high
and only a few specialised institutions worldwide, located almost
exclusively in developed countries, are able to contribute to this
newly-evolving science. Although no immediate spin-off for
agricultural applications should be expected in the next 5-10 years,
a detailed knowledge of plant and animal genomes will, in the long
run, speed up breeding, also in tropical agriculture.
Genetic modification
Genetic modification, also termed genetic manipulation,
concerns the transfer of genetic information - in the form of DNA
sequences - across sexual barriers between species, which under
normal conditions would not exchange DNA. The resulting
organisms are called genetically modified organisms (GMOs) or
transgenics. Genetic modification is currently used only to
introduce a single new trait, which might be based on the activity
of a single gene, or a small number of genes. The number of
genes with known functions that has been isolated is still too
small to allow for more complicated traits or combinations of
traits to be introduced using genetic modification. In agriculture,
genetic modification has been applied in a number of major
crops. The majority of these applications involve the introduction
of resistant traits, particularly to herbicides and insects. A smaller
number of applications involve the quality of the resulting
product, e.g. the shelf life of tomatoes, or the production of
alternative sweeteners in sugarbeet. Whereas farmers mainly deal
with the former type of agronomic applications, the processing
industry and consumers are confronted with the latter. Transgenic
animals have been produced under laboratory conditions, but up
to now have not been released for industrial application.
In all cases, the costs of developing GMOs are high, and 
the technology is dependent on very expensive facilities and
highly skilled experts. The cost of the development and
commercialisation of a GMO crop variety was recently estimated
at US$30 million. In an increasing number of countries, legislation
and regulations to contain GMOs and their products during the
development and extensive testing phases before release are strict
and costly. Although 70 transgenic crop varieties were registered
for commercial cultivation in 1999, as of now international
agricultural biotechnology companies have focussed their
activities on a few crops, including the seed companies’ cash
earners such as cotton, rapeseed, maize, soybean, and wheat.
Impact on tropical agriculture
In developed countries agriculture has been industrialised over
the course of the twentieth century. Breeding has developed from
a farmer’s activity into a specialist’s affair. The conditions of the
farmers’ fields have been adjusted to the new breeds by extensive
application of fertilisers and pesticides. Crops have become
increasingly uniform to facilitate mechanised cultivation,
harvesting and processing. Because of the more capital-intensive
nature of agriculture, the size of an average economically
sustainable farm has increased several times over the last century.
Agricultural biotechnology will certainly enhance this trend by
increasing the dependence of the entire production chain on a
very limited number of crops and varieties with new traits.
Modern agriculture will continue to be high-input dependent and
become even more uniform. Genetic modification will allow the
production of the same raw materials (e.g. plant oils) in different
crops. The negative impact of modern agriculture on
agrobiodiversity might be worsened by the wide-scale
introduction of genetically modified crops and farm animals.
Tropical agriculture, however, is still dominated by small-scale
systems. Often, farmers’access to external inputs is low. Therefore,
international companies developing GM crops do not consider
small-scale agriculture as an important market. Besides, GM crops
would not cater to the diverse agro-ecological conditions
Tissue culture can be useful for small farmers. Photo: AgroIndia
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encountered in farmers’ fields and would be of little benefit to them.
The field release of GMOs is generally heavily regulated and
major short-term effects on the crops and the agro-system
environment are expected to show up in the test phase. Yet, small-
scale systems may well have to face the environmental risks of
GMOs. In the long term it is difficult to imagine how the
appearance of GMO traits in non-GMO crops can be avoided as a
result of uncontrolled crossing, particularly in cross-fertilising
species. The question is whether we regard this an unacceptable
tinkering of nature, a risky development in terms of food safety
and environmental and genetic pollution, or simply as a new
harmless step in the interference of humans on the plants and
animals that provide our food. In any case, it will certainly pose
problems to the organic agriculture sector that is devoted to the
maintenance of a GMO-free chain.     
Although GMOs may currently have little or no direct
relevance to small-scale tropical agriculture, this reality does not
follow from the biological nature of biotechnological applications
but from the socio-economic context in which biotechnological
applications are developed. This leads us to the question of
whether and under what conditions other appropriate
biotechnologies for small-scale farmers are feasible. 
Appropriate biotechnologies: a reality or fantasy?
Biotechnology has the potential to serve all farmers, including
small-scale farmers in tropical production systems. Appropriate
biotechnologies may be developed on the basis of demand and in
consultation with farmers and/or their representatives (community-
based organisations, supportive NGOs, dedicated extension
services). It can be expected that modern biotechnologies that
require relatively few investments and that can be applied in-
country or even in the community stand the best chance of being
appropriate. In particular, this could apply to plant tissue culture
technology to produce healthy, much valued varieties in large
enough quantities. Also the use of monoclonals may in time allow
farmers and extension services to monitor for specific pests and
diseases. The use of artificial insemination could be extended also
to well-adapted indigenous breeds. Cryopreservation and tissue
culture of valuable plant and animal varieties and breeds might also
serve the small-scale farming sector in providing a back-up for
their genetic resources maintained in the field. All these
applications form a potential reality.
However, it can be doubted whether genetic modification has
anything to offer to small-scale farmers other than a growing
dependence of farmers on the seed industry. It can be doubted
whether and to which extent the lack of interest by the private
sector will be compensated for by increased public breeding
efforts that should prevent a widening technology gap between a
rather small number of commercial crops and crops of regional
or local importance. On the other hand, it should be realised that
for any application in the public domain aimed at benefiting
small-scale farmers, co-operation with the private sector will be
absolutely indispensable since the private sector owns all the key
patents needed to develop GMOs. The case of Golden Rice
forms an interesting one as it represents an exceptional effort in
the public domain to alleviate problems of low-income groups
including many small-scale farmers in developing countries
(vitamin A deficiency) through the application of genetic
modification. However, many patent exemptions in the form of
licences had to be obtained to allow Golden Rice to be developed
for farmers in developing countries, and whether Golden Rice
will fit social and cultural patterns will have to be awaited. Also,
it is yet too early to predict how often such patent exemptions
will be granted to allow the development of public sector
initiatives to benefit the small-scale sector. 
In my opinion, more than the risks of monster organisms, food
safety problems and environmental pollution, the real threat of
GMOs might be the socio-economic dependence it creates for its
users from the companies selling such GMOs.
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